Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adynovate Prophylaxis in Chinese Severe Hemophilia A
NCT05707351Phase 3Completed
- Sponsor
- Takeda
- Start
- Mar 2023
- Primary completion
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant coagulation factor viii in hemophilia A, sponsored by Takeda. Started Mar 2023; status: completed.
02
Drugs
recombinant coagulation factor viii
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT05707351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05707351.